Back to Stock Dashboard
Sector:
Healthcare
Add to portfolio
INBS
Intelligent Bio Solutions Inc.
CAPPED RATING
Intelligent Bio Solutions Inc. (INBS) is rated C (2.5/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B); its weakest is Momentum (D).
Quantitative Factor Evaluation • Updated
Overall Rating
2.5
/ 5.0
C
Value
B
Factor Score
3.3
/ 5.0
Growth
B
Factor Score
3.2
/ 5.0
Profitability
D+
Factor Score
1.8
/ 5.0
Momentum
D
Factor Score
1.4
/ 5.0
Revisions
C+
Factor Score
2.6
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
6.0
EV / EBITDA
-0.4
Rev Growth YoY
35.8%
Gross Margin
48.6%
Price Return 3M
-30.0%
Price Return 12M
-73.3%
Catalyst Signal
0.00
Market Cap
$7.0M
TTM Revenue
$4.2M
Price / Sales
1.7
ROE
-307.7%
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-12 | B (3.3) | B (3.2) | D+ (1.8) | D (1.4) | C+ (2.6) | C (2.5) |
| 2026-11-05 | B (3.3) | B (3.3) | C- (1.9) | C- (2.0) | C+ (2.7) | C+ (2.6) |
| 2026-10-29 | B (3.4) | B (3.2) | C- (1.9) | C (2.2) | C+ (2.7) | C+ (2.7) |
| 2026-10-22 | B (3.3) | B (3.2) | C- (1.9) | C- (2.0) | C+ (2.6) | C+ (2.6) |
| 2026-10-15 | B (3.3) | B (3.2) | C- (1.9) | D+ (1.5) | C+ (2.6) | C+ (2.5) |
Page
1
of
4